Interview Merril

We've seen Adaptive Phage Therapeutics (APT) in the news a lot lately—here's an interview with Greg Merril, APT's CEO, a podcast interview with a patient whose leg was saved by APT's phages, and a news article on APT's selection for Startup Grind's Global Accelerate Conference (top 1% of 4000 biotech companies!).